Cover ImageSALE
Market Research Report

Global Endocrine Testing Market 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 332633
Published Content info 101 Pages
Immediate Delivery Available
Price
Back to Top
Global Endocrine Testing Market 2015-2019
Published: June 10, 2015 Content info: 101 Pages
Description

About Endocrine Testing Systems

Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body.

Technavio's analysts forecast the global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019.

Covered in this Report

In this report, Technavio covers the present scenario and the growth prospects of the global endocrine testing market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies:

  • Types of Diagnostic Technologies
  • Clinical chemistry technologies
  • Immunoassay technologies
  • Tandem mass spectrometry
  • Monoclonal and polyclonal antibodies
  • Sensor technologies
  • Others

The report also provides information about the following endocrine tests:

  • FSH
  • TSH
  • hCG
  • DHEAS
  • Progesterone
  • Testosterone
  • Insulin
  • Prolactin
  • Cortisol
  • Estradiol
  • Luteinizing Hormone

This report covers the present scenario and the growth prospects of the endocrine testing market for the period 2015-2019 mainly for three regions:

  • Americas: The principal countries in the Americas are the US, Canada, Mexico, and Brazil.
  • EMEA: The principal countries focused in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE.
  • APAC: The principal countries focused in this region are Japan, China, Australia, Singapore, South Korea, and India.

Technavio's report, Global Endocrine Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Diagnostics
  • Diascorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific

Other Prominent Vendor

  • AdnaGen
  • Alere
  • Allele Biotechnology
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Diametra
  • Enzo Life Sciences
  • Fujirebio
  • ImmunoDX
  • Immunonodiagnostics System
  • InDevR
  • Innogenetics
  • Kyowa Medex
  • Merck Millipore
  • Meridian Bioscience
  • Meso Scale Discovery
  • NanoEnTek
  • Nova Century Scientific
  • Ortho-Clinical Diagnostics
  • Quidel
  • Randox
  • SDIX
  • Sysmex
  • Tecan
  • Tosoh Bioscience
  • Vital Diagnostics
  • ZEUS Scientific

Market Driver

  • Growing Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • Limited Detection and Complexity of Immunoassays
  • For a full, detailed list, view our report

Market Trend

  • Automation and System Integration
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Table of Contents
Product Code: IRTNTR6125

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Tests

08. Market Segmentation by Diagnostic Technology

  • 08.1. Global Clinical Chemistry Technology Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Immunoassay Technology Market
    • 08.2.1. Market Size and Forecast
  • 08.3. Global Monoclonal and Polyclonal Antibodies Technology Market
    • 08.3.1. Market Size and Forecast
  • 08.4. Global Tandem Mass Spectrometry Technology Market
    • 08.4.1. Market Size and Forecast
  • 08.5. Global Sensor Technology Market
    • 08.5.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. Endocrine Testing Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Endocrine Testing Market in EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. Endocrine Testing Market in APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
    • 17.2.1. Abbott
    • 17.2.2. DiaSorin
    • 17.2.3. Roche
    • 17.2.4. Siemens Healthcare
    • 17.2.5. Thermo Fisher
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Diagnostics
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Geographical Presence
    • 18.1.4. SWOT Analysis
  • 18.2. DiaSorin
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Roche Diagnostics
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2014
    • 18.3.4. Business Segmentation by Revenue 2013 and 2014
    • 18.3.5. Geographical Segmentation by Revenue 2014
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Siemens Healthcare Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. SWOT Analysis
  • 18.5. Thermo Fisher Scientific
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation by Revenue 2014
    • 18.5.4. Business Segmentation by Revenue 2013 and 2014
    • 18.5.5. Geographical Segmentation by Revenue 2014
    • 18.5.6. Business Strategy
    • 18.5.7. Recent Developments
    • 18.5.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Snapshot of Global Endocrine Testing Market 2014-2019
  • Exhibit 3: Global Endocrine Testing Market 2014-2019 ($ millions)
  • Exhibit 4: Global Endocrine Testing Market Segmentation by Type of Tests
  • Exhibit 5: Global Endocrine Testing Market Segmentation by Type of Tests 2014
  • Exhibit 6: Normal FSH Level (depends on age and gender)
  • Exhibit 7: TSH Standard Reference Levels
  • Exhibit 8: TSH Levels during Pregnancy
  • Exhibit 9: hCG Levels in Early Pregnancy
  • Exhibit 10: DHEAS Levels
  • Exhibit 11: Progesterone Levels During Different Phases of the Menopause Cycle and Pregnancy
  • Exhibit 12: Normal Levels of Testosterone
  • Exhibit 13: Glucose Levels
  • Exhibit 14: Standard Levels of Prolactin
  • Exhibit 15: Normal Cortisol Levels
  • Exhibit 16: Normal Estradiol Levels
  • Exhibit 17: Normal LH Levels
  • Exhibit 18: Segmentation of Global Endocrine Testing Market by Type of Diagnostic Technology
  • Exhibit 19: Segmentation of Global Endocrine Testing Market by Technology 2014
  • Exhibit 20: Global Clinical Chemistry Technology Market 2014-2019 ($ millions)
  • Exhibit 21: Global Immunoassay Technology Market 2014-2019 ($ millions)
  • Exhibit 22: Global Monoclonal and Polyclonal Antibodies Technology Market 2014-2019 ($ millions)
  • Exhibit 23: Global Tandem Mass Spectrometry Technology Market 2014-2019 ($ millions)
  • Exhibit 24: Global Sensor Technology Market 2014-2019 ($ millions)
  • Exhibit 25: Global Endocrine Testing Market Segmentation Analysis 2014-2019
  • Exhibit 26: Segmentation of Global Endocrine Testing Market by Type of Technology 2014-2019
  • Exhibit 27: Global Endocrine Testing Market by Geographical Segmentation 2014
  • Exhibit 28: Endocrine Testing Market in Americas 2014-2019 ($ millions)
  • Exhibit 29: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 30: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 31: Global Endocrine Testing Market by Geography 2014-2019 in ($ millions)
  • Exhibit 32: Global Endocrine Testing Market by Geography 2014-2019
  • Exhibit 33: Percentage of Elderly Aged above 65 in Different Regions 2012 and 2050
  • Exhibit 34: Estimated Percentage of Elderly Population 2012 and 2050
  • Exhibit 35: Abbott: Key Takeaways
  • Exhibit 36: DiaSorin: Revenue by Technology 2014
  • Exhibit 37: DiaSorin: Key Takeaways
  • Exhibit 38: Roche: Key Takeaways
  • Exhibit 39: Siemens Healthcare: Key Takeaways
  • Exhibit 40: Thermo Fisher: Key Takeaways
  • Exhibit 41: Abbott Diagnostics: Geographical Presence
  • Exhibit 42: DiaSorin: Business Segmentation by Revenue 2013
  • Exhibit 43: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 44: DiaSorin: Geographical Segmentation by Revenue 2013
  • Exhibit 45: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 46: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 47: Roche Diagnostics: Geographical Segmentation by Revenue 2014
  • Exhibit 48: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
  • Exhibit 49: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 50: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
Back to Top